Entero Healthcare Solutions Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 141.65 | 154.56 | 148.96 |
| Operating Expense | 118.91 | 124.23 | 115.75 |
| Net Profit | 15.33 | 20.88 | 37.28 |
| Net Profit Margin | 10.82 | 13.51 | 25.03 |
| Earning Per Share | 3.52 | 4.80 | 10.19 |
| EBIDTA | 19.82 | 27.28 | 44.62 |
| Effective Tax Rate | 8.66 | 12.60 | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 141.65 |
| Operating Expense | 118.91 |
| Net Profit | 15.33 |
| Net Profit Margin | 10.82 |
| Earning Per Share | 3.52 |
| EBIDTA | 19.82 |
| Effective Tax Rate | 8.66 |
Invest in Entero Healthcare Solutions Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 318.16 | 177.69 | 137.29 |
| Operating Expenses Annual | 352.66 | 221.61 | 191.00 |
| Operating Profit Annual | 55.43 | 8.65 | -26.84 |
| Interest Annual | 22.32 | 11.30 | 5.29 |
| Depreciation | 8.35 | 9.18 | 8.22 |
| Net Profit Annual | 38.44 | -12.46 | -40.85 |
| Tax Annual | -14.08 | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 318.16 |
| Operating Expenses Annual | 352.66 |
| Operating Profit Annual | 55.43 |
| Interest Annual | 22.32 |
| Depreciation | 8.35 |
| Net Profit Annual | 38.44 |
| Tax Annual | -14.08 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 6.12 | 30.20 | 16.22 |
| Cash Flow from Operations | -75.65 | -56.91 | -44.70 |
| Cash Flow from Investing | -762.69 | -58.29 | -68.80 |
| Cash Flow from Financing | 925.56 | 91.11 | 127.48 |
| Cash Flow at the End | 93.34 | 6.12 | 30.20 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 6.12 |
| Cash Flow from Operations | -75.65 |
| Cash Flow from Investing | -762.69 |
| Cash Flow from Financing | 925.56 |
| Cash Flow at the End | 93.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 17.42 | 4.87 | -19.55 |
| PBIT Margin (%) | 14.67 | -0.65 | -25.89 |
| PBT Margin (%) | 14.01 | -0.59 | -21.00 |
| Net PROFIT Margin (%) | 12.08 | -7.01 | -29.75 |
| Return On Networth / Equity (%) | 4.83 | TBA | TBA |
| Return On Networth /Employed (%) | 3.91 | TBA | TBA |
| Return On Assets (%) | 3.26 | -1.89 | -7.44 |
| Total Debt / Equity (X) | 0.06 | 0.15 | 0.08 |
| Asset Turnover Ratio (%) | 0.27 | 0.27 | 0.25 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 17.42 |
| PBIT Margin (%) | 14.67 |
| PBT Margin (%) | 14.01 |
| Net PROFIT Margin (%) | 12.08 |
| Return On Networth / Equity (%) | 4.83 |
| Return On Networth /Employed (%) | 3.91 |
| Return On Assets (%) | 3.26 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 0.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 34.44 | 40.65 | 51.47 |
| Total Current Assets Annual | 1,660.99 | 673.00 | 557.27 |
| Non Current Assets Annual | 107.60 | 90.56 | 96.82 |
| Total Shareholders Funds Annual | 1,626.41 | 583.73 | 551.21 |
| Total Assets Annual | 1,768.58 | 763.57 | 654.08 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 34.44 |
| Total Current Assets Annual | 1,660.99 |
| Non Current Assets Annual | 107.60 |
| Total Shareholders Funds Annual | 1,626.41 |
| Total Assets Annual | 1,768.58 |
EPS (INR)
Expected
5.43
Reported
5.43
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 18.88%
